Market open
Bio-Techne/$TECH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bio-Techne
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Ticker
$TECH
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
3,100
ISIN
US09073M1045
Website
Bio-Techne Metrics
BasicAdvanced
$7.9B
59.98
$0.83
1.46
$0.32
0.64%
Price and volume
Market cap
$7.9B
Beta
1.46
52-week high
$85.57
52-week low
$46.01
Average daily volume
2.3M
Dividend rate
$0.32
Financial strength
Current ratio
3.707
Quick ratio
2.233
Long term debt to equity
20.29
Total debt to equity
20.986
Dividend payout ratio (TTM)
38.45%
Interest coverage (TTM)
13.77%
Management effectiveness
Return on assets (TTM)
5.05%
Return on equity (TTM)
6.53%
Valuation
Price to earnings (TTM)
59.977
Price to revenue (TTM)
6.509
Price to book
3.88
Price to tangible book (TTM)
12.93
Price to free cash flow (TTM)
35.641
Dividend yield (TTM)
0.64%
Forward dividend yield
0.64%
Growth
Revenue change (TTM)
4.72%
Earnings per share change (TTM)
-34.18%
3-year revenue growth (CAGR)
3.94%
3-year earnings per share growth (CAGR)
-15.44%
What the Analysts think about Bio-Techne
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Bio-Techne stock.
Bio-Techne Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Bio-Techne Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Bio-Techne News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market open
Upcoming events
May19
Bio-Techne
Dividend·Ex-dividend
May30
Bio-Techne
Dividend·Payment
$0.08Per share
FAQs
What’s the current market cap for Bio-Techne stock?
Bio-Techne (TECH) has a market cap of $7.9B as of May 09, 2025.
What is the P/E ratio for Bio-Techne stock?
The price to earnings (P/E) ratio for Bio-Techne (TECH) stock is 59.98 as of May 09, 2025.
Does Bio-Techne stock pay dividends?
Yes, the Bio-Techne (TECH) stock pays dividends to shareholders. As of May 09, 2025, the dividend rate is $0.32 and the yield is 0.64%. Bio-Techne has a payout ratio of 38.45% on a trailing twelve-month basis.
When is the next Bio-Techne dividend payment date?
The next Bio-Techne (TECH) dividend payment is scheduled for May 30, 2025.
What is the beta indicator for Bio-Techne?
Bio-Techne (TECH) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.